Prediabetes

SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.

INDIANAPOLIS — A positive relationship exists between corneal hysteresis and HbA1c and increased blood glucose, suggesting its use as a noninvasive biomarker in patients with glucose dysregulation, according to a presenter at Academy 2024.

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.

Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health complications, according to an expert.

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.

Clinical and genetic risk factors can help identify individuals at risk for immune checkpoint inhibitor-induced diabetes, according to results of a cohort study.

In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those without any risk factors, according to new findings from the REPRIEVE trial.

In this video, David Nathan, MD, discusses the effects of COVID-19 on patients with type 2 diabetes.

In this video, David Nathan, MD, discusses the action needed by primary care physicians to help inform and treat patients at risk for type 2 diabetes.

Researchers found that women who slept less than 7 hours per night at 24 to 28 weeks’ gestation were more likely to have a child with neurodevelopmental delays compared with those who slept 7 hours or more per night.